The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical genomic implications of transcriptional subtypes in pancreatic cancer.
 
Harshabad Singh
Research Funding - AstraZeneca/Daiichi Sankyo
(OPTIONAL) Uncompensated Relationships - Natera; Seagen
 
Kevin S Kapner
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Alex Patrick Farrell
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Jimmy Guo
Patents, Royalties, Other Intellectual Property - Through Broad Institute
 
Rishi Surana
No Relationships to Disclose
 
Kimberly Perez
Consulting or Advisory Role - Celgene; Eisai; Helsinn Therapeutics/QED Therapeutics; Lantheus Medical Imaging
 
James M. Cleary
Honoraria - Blueprint Medicines; Incyte; Syros Pharmaceuticals
Research Funding - Apexigen; Arcus Biosciences; Arcus Biosciences; AstraZeneca; Bayer; BMS (Inst); BMS (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Incyte; Roche
 
Srivatsan Raghavan
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Patents through DFCI and Broad Institute
 
Benjamin Adam Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Honoraria - Rafael Pharmaceuticals
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bayer; DoMore Diagnostics; HalioDx; Merus NV
Speakers' Bureau - AstraZeneca; Bayer; Diiachi Sankyo; HalioDx; Lilly; Seagen; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Ipsen (Inst); Isofol Medical (Inst); Novartis (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Caris Life Sciences; Merus NV
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; IDEAYA Biosciences; Merck; Merus; Novartis; Pfizer; Pionyr; Seagen; TriSalus Life Sciences
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); RenovoRx (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma
 
Rachna T. Shroff
Consulting or Advisory Role - AstraZeneca; Basilea; Boehringer Ingelheim; Exelixis; Genentech; Incyte; Merck; QED Therapeutics; SERVIER; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Faeth Therapeutics; Immunovaccine; Loxo/Lilly; Merck; NGM Biopharmaceuticals; Novocure; Nucana; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen; Taiho Pharmaceutical
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - Amgen; Merck
Research Funding - BeiGene (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); PharmaMar (Inst); Takeda (Inst); TLC PharmaChem (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Stephanie Dougan
Stock and Other Ownership Interests - Kojin Therapeutics
Consulting or Advisory Role - Kojin Therapeutics; Neoleukin Therapeutics (I)
Research Funding - Bristol-Myers Squibb; Genocea Biosciences; Lilly; Lilly (I); Novartis (I); Novartis Institutes for BioMedical Research
 
Jonathan Nowak
Research Funding - Illumina; NanoString Technologies
 
David Spetzler
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Caris Life Sciences
Research Funding - Caris Life Sciences
Patents, Royalties, Other Intellectual Property - Caris Life Sciences holds and has pending patents with intellectual property interests relating to health and medicine.
Travel, Accommodations, Expenses - Caris Life Sciences
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Pionyr; Syndax; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; G1 Therapeutics; GRAIL; Synaffix; Syndax; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Tessa Therapeutics; Verseau Therapeutics
 
Brian M. Wolpin
Honoraria - Celgene; G1 Therapeutics; Mirati Therapeutics
Consulting or Advisory Role - BioLineRx; Celgene; G1 Therapeutics; Genentech; GRAIL; Mirati Therapeutics
Research Funding - Celgene; Lilly; Novartis; Revolution Medicines
 
Andrew Aguirre
Stock and Other Ownership Interests - Riva Therapeutics
Honoraria - Phillips Gilmore Oncology
Consulting or Advisory Role - Alcon (I); Arrakis Therapeutics; AstraZeneca; Boehringer Ingelheim; Merck; Mirati Therapeutics; Nimbus Therapeutics; Plexium; Revolution Medicines; Riva Therapeutics; SERVIER; Syros Pharmaceuticals; T-Knife
Research Funding - Bristol-Myers Squibb/Celgene; Deerfield Management; Mirati Therapeutics; Novartis; Novo Ventures; Revolution Medicines; Syros Pharmaceuticals